KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea
· Delayed Price · Currency is KRW 11,850
+100 (0.85%)
At close: Apr 29, 2026
KOREA PHARMA Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 129,244 | 141,787 | 166,982 | 257,943 | 233,403 | 529,520 | Upgrade
|
| Market Cap Growth | -17.71% | -15.09% | -35.26% | 10.51% | -55.92% | 118.69% | Upgrade
|
| Enterprise Value | 140,652 | 146,597 | 151,067 | 248,815 | 222,946 | 528,191 | Upgrade
|
| Last Close Price | 11850.00 | 13000.00 | 15251.21 | 23482.14 | 21200.57 | 47987.24 | Upgrade
|
| PE Ratio | - | - | 44.04 | 3079.40 | - | 83.15 | Upgrade
|
| Forward PE | - | 82.10 | 82.10 | 82.10 | 82.10 | 112.13 | Upgrade
|
| PS Ratio | 1.48 | 1.62 | 2.05 | 3.10 | 2.88 | 6.65 | Upgrade
|
| PB Ratio | 1.88 | 2.06 | 2.34 | 3.76 | 3.90 | 9.21 | Upgrade
|
| P/TBV Ratio | 1.97 | 2.17 | 2.48 | 3.96 | 4.10 | 9.72 | Upgrade
|
| P/FCF Ratio | - | - | 34.81 | 78.44 | 40.14 | 114.12 | Upgrade
|
| P/OCF Ratio | 48.11 | 52.78 | 20.75 | 53.52 | 28.19 | 73.62 | Upgrade
|
| EV/Sales Ratio | 1.61 | 1.67 | 1.86 | 2.99 | 2.75 | 6.64 | Upgrade
|
| EV/EBITDA Ratio | 70.27 | 64.31 | 17.01 | 28.75 | 26.02 | 71.46 | Upgrade
|
| EV/EBIT Ratio | - | - | 24.82 | 42.60 | 36.03 | 105.34 | Upgrade
|
| EV/FCF Ratio | -8.29 | - | 31.49 | 75.67 | 38.34 | 113.83 | Upgrade
|
| Debt / Equity Ratio | 0.57 | 0.57 | 0.32 | 0.51 | 0.91 | 0.94 | Upgrade
|
| Debt / EBITDA Ratio | 17.08 | 17.08 | 2.58 | 4.03 | 6.38 | 7.27 | Upgrade
|
| Debt / FCF Ratio | - | - | 4.77 | 10.60 | 9.40 | 11.58 | Upgrade
|
| Net Debt / Equity Ratio | 0.17 | 0.17 | -0.21 | -0.20 | -0.14 | -0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.00 | 5.00 | -1.66 | -1.55 | -0.99 | -1.19 | Upgrade
|
| Net Debt / FCF Ratio | -0.67 | -0.67 | -3.08 | -4.09 | -1.45 | -1.90 | Upgrade
|
| Asset Turnover | 0.73 | 0.73 | 0.70 | 0.66 | 0.62 | 0.76 | Upgrade
|
| Inventory Turnover | 2.74 | 2.74 | 2.46 | 2.59 | 2.67 | 2.40 | Upgrade
|
| Quick Ratio | 0.74 | 0.74 | 2.76 | 1.89 | 1.14 | 3.13 | Upgrade
|
| Current Ratio | 1.14 | 1.14 | 3.81 | 2.56 | 1.41 | 3.81 | Upgrade
|
| Return on Equity (ROE) | -3.77% | -3.77% | 5.42% | 0.13% | -1.91% | 12.25% | Upgrade
|
| Return on Assets (ROA) | -0.46% | -0.46% | 3.26% | 2.89% | 2.97% | 2.97% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.14% | -1.30% | 10.57% | 0.46% | 12.37% | 11.11% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.30% | -1.30% | 6.50% | 6.60% | 10.10% | 4.80% | Upgrade
|
| Earnings Yield | -2.04% | -1.86% | 2.27% | 0.03% | -0.48% | 1.20% | Upgrade
|
| FCF Yield | -13.12% | -11.96% | 2.87% | 1.27% | 2.49% | 0.88% | Upgrade
|
| Payout Ratio | - | - | 14.38% | 651.04% | - | 8.56% | Upgrade
|
| Buyback Yield / Dilution | -0.14% | -0.14% | 9.83% | -11.22% | 1.22% | -12.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.